期刊名称：JOURNAL OF CONTROLLED RELEASE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
The journal publishes papers on the science and technology of the controlled release and delivery of drugs and other agents. The terms "controlled release" and "delivery" are used in their broadest sense to include mechanisms such as diffusion, chemical and enzymatic reactions, dissolution, osmosis, targeting, and the utilization and manipulation of biological processes. A broad spectrum of papers dealing with all aspects of controlled release and delivery, including gene delivery, tissue engineering and diagnostic agents, is encouraged. The use of prodrugs and carriers such as water-soluble polymers, micro- and nanoparticles, liposomes and micelles is included in the scope. Relevant papers on the toxicology and biocompatibility of drug delivery systems are also published.
In addition to original full length papers, notes, reviews and rapid communications, the journal includes book reviews, reports of future meetings, and announcements pertaining to the activities of the Controlled Release Society
|
|
Instructions to Authors
1. Scope of the journal
The journal publishes papers on the science and technology of the controlled release and delivery of drugs and other agents. The terms "controlled release" and "delivery" are used in their broadest sense to include mechanisms such as diffusion, chemical and enzymatic reactions, dissolution, osmosis, targeting, and the utilization and manipulation of biological processes. A broad spectrum of papers dealing with all aspects of controlled release and delivery, including gene delivery, tissue engineering and diagnostic agents, is encouraged. The use of prodrugs and carriers such as water-soluble polymers, micro- and nanoparticles, liposomes and micelles is included in the scope. Relevant papers on the toxicology and biocompatibility of drug delivery systems are also published.
In addition to original full length papers, notes, reviews and rapid communications, the journal includes book reviews, reports of future meetings, and announcements pertaining to the activities of the Controlled Release Society. Persons considering writing a review are encouraged to contact the Review Editor.
2. Preparation of manuscripts
Manuscript Types
Full length papers are not limited in length and should include Title, Abstract, Methods and Materials, Results, Discussion, Conclusions, Acknowledgments and References (see below). Rapid Communications are preliminary reports of research that are of sufficient importance and general interest that accelerated publication is justified. The length is limited to 1000 words. Notes are shorter manuscripts, limited to 1500 words, that describe studies of general interest and significance, but which may be limited in scope.
General procedures
The language of the Journal is English. Three copies of the manuscript, typed with double spacing and ample margins, should be submitted. The following format and order of presentation is suggested:
Title, author(s), address(es). The title should be no longer than 100 letters and spaces. The address should include the country mailing or *Zip* code when available, as well as the telephone and fax numbers, and e-mail address. Indicate to whom correspondence and proofs should be sent.
Abstract. The abstract should present a summary of the problem, scientific method, major findings and conclusions, in no more than 200 words and one paragraph. Unsubstantiated speculation should not be included. Footnotes may not be used. References, if cited, must provide complete publication data.
Keywords (5)
Introduction. The purpose of this section is not to review the literature, but to briefly introduce the objective of the research and its significance.
Materials and methods. Procedures should be described in sufficient detail to permit others to repeat and reproduce the results of the work. Sources of commercial products need not be listed unless unique. Published methods need not be restated but must be referenced. Where the reference is to papers under review or in press, copies should be provided to the Editor to facilitate review.
Results. Tables and Figures that summarize the results and improve their comprehension are encouraged, but only if the space required is not excessive and less than can be stated in the text. The number of Tables and Figures will generally be restricted to 4 and 8 in number, respectively. The reproducibility and statistical significance of measurements, material or biological, must be included when relevant.
Discussion. This section should deal with the interpretation of the results and their significance to the field of study. Repetition of information presented in other sections should be avoided, as should general reviews of the literature. In some cases it may be advantageous to combine the Results and Discussion sections.
Conclusion. A short, one paragraph summary of the most important finding(s) of the research.
Acknowledgment (if any). Recognition of financial support, technical assistance and advice.
References. Number consecutively throughout the text and supply a separate Reference List. Abbreviate according to the 'Bibliographic Guide for Editors and Authors', 1974 (Chemical Abstracts Service, The Ohio State University, Columbus, OH 43210) and the 'List of Serial Title Word Abbreviations', 1985, ISDS, 20 rue Bachaumont, 75002 Paris, France; ISBN 2-904938-02-8. Examples:
Journal:
[1] E. Porges, B. Schade, W. Ropte, Automated flow-through method to determine the dissolution rate of slightly soluble substances, Pharm. Ind. 47(1) (1985) 77-86.
Book:
[2] A.R. Gennaro, Remington's Pharmaceutical Sciences, XXII, Mack Publishing Company, Easton, PA, 1990.
Book Chapter:
[3] S.L. Ali, Nifedipine, in: K. Florey (Ed.), Analytical Profiles of Drug Substances, Vol. 18, Academic Press, New York, 1989, pp. 221-288.
Patent:
[4] J.B. Phipps, D.F. Untereker, Iontophoresis apparatus and methods of producing same, U.S. Patent 4, 744, 787, May 17, 1988.
Report:
[5] N.F. Cardarelli, K.E. Walker, G. Zweig, Development of registration criteria for controlled release pesticide formulations, U.S. Environmental Protection Agency, Washington, DC 20460, EPA-504/9077-916, January 1978.
Tables. Number consecutively and type on a numbered, separate page. Please use arabic numerals and supply a heading. Column headings should be explanatory and carry units.
Figures. Number consecutively with arabic numerals. Please supply one original and two additional copies. Number all line drawings on the front and all photos on the back and add the author's name. Indicate the top of all photographs and line drawings when there may be doubt. Supply a list of captions on a separate page. All photographs must be glossy black-white prints. All line drawings must be drawn in Indian ink on drawing-paper. High-resolution computer print-outs are also acceptable. All lettering and artwork must be sufficiently clear and open to take a two- or three-fold reduction. Colour reproduction is available at cost. The 2003 price for colour figures is 272 Euro for the first page and 182 Euro for subsequent pages.
Units and abbreviation. SI units should be used: English units or other equivalents should be given in parentheses if necessary. On graphs, if values are recorded in non-SI units, then additional scales in SI units should be used. If a large number of symbols are used, it is helpful if authors submit a list of these symbols and their meanings.
Electronic manuscripts
After final acceptance for publication, your revised manuscript must be submitted on disk, together with two identical printed hard copies, to the accepting Editor. It is important that the file on disk and the printed copies be identical. Electronic files can be submitted on floppy disks, ZIP/JAZ disks, or CD-ROM. Do not split the manuscript into separate files (title page as one file, text as another, etc.). Ensure that the letter "l" and digit "1" (also letter "O" and digit "0") have been used properly, and format your article (tabs, indents, etc.) consistently. Characters not available on your wordprocessor (Greek letters, mathematical symbols, etc.) should not be left open but indicated by a unique code (e.g., gralpha, @, #, etc., for the Greek letter  ). Such codes should be used consistently throughout the entire text. Please make a list of such codes and provide a key. Do not allow your wordprocessor to introduce word splits and do not use a `justified' layout. Please adhere strictly to the general instructions on style/arrangement and, in particular, the reference style of the journal. It is very important that you save your file in the wordprocessor format. If your wordprocessor features the option to save files "in flat ASCII", please do not use it. Format your disk correctly and ensure that only the relevant file (one complete article only) is on the disk. Also, specify the type of computer and wordprocessing package used, label the disk with your name and the name of the file on the disk.
Additional instructions on how to prepare your manuscript can be found at: http://authors.elsevier.com/quickguide . More in-depth guidelines for submitting artwork/illustrations can be found at: http://authors.elsevier.com/artwork .
3. Submission
Three copies of the complete manuscript and illustrations should be sent to the Editor responsible for your region.
Please include full contact information - corresponding author name, e-mail address, telephone and fax numbers, and full postal address. Persons considering submitting a review are encouraged to contact the Review Editor. Book reviews are by invitation only.
Editor-in-Chief (North and South America Submissions)
Dr. C.G. Pitt, 1374 Hanover Lane, Ventura, CA 93001, USA; e-mail: cpitt@prodigy.net
European Editor (Europe, Middle East and Africa Submissions)
Prof. W.E. Hennink, Department of Pharmaceutics, University of Utrecht, Sorbonnelaan 16, 3508 TB Utrecht, The Netherlands; e-mail: jcr@pharm.uu.nl
Japan and Far East Editors (Japan, Far East, Australia, New Zealand Submissions)
Prof. T. Nagai, Editor; e-mail: nagaijcr@hoshi.ac.jp
Prof. K. Takayama, Associate Editor
Department of Pharmaceutics, Hoshi University, Ebara, Shinagawa-ku, Tokyo 142-8501, Japan; e-mail: takayama@hoshi.ac.jp
Review Editor
Prof. V.P. Torchilin, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Mugar Building, Room 312, 360 Huntington Ave, Boston, MA 02115, USA; e-mail: vtorchil@lynx.neu.edu
Book Review Editor
Prof. R.A. Siegel, Department of Pharmaceutics WDH 9-177, University of Minnesota, 308 Harvard St. SE, Minneapolis, MN 55455, USA; e-mail: siege017@tc.umn.edu
Copyright regulations for authors
Upon acceptance of an article by the Journal, author(s) will be asked to transfer the copyright of the article to the publisher. This transfer will ensure the widest possible dissemination of information.
5. Correcting proofs and reprints
Elsevier Science is now sending PDF proofs to authors by e-mail for correction. If an author is unable to handle this process, regular print proofs will be sent. Elsevier Science will do everything possible to get the article corrected and published as quickly and accurately as possible. Therefore, it is important to ensure that all corrections are sent back in one communication. Subsequent corrections will not be possible. Only typesetting errors may be corrected; no changes in, or additions to, the accepted manuscript will be allowed. Proofs should be returned to Elsevier Science within 48 hours.
The Journal of Controlled Release has no page charges. Twenty-five offprints of each paper will be supplied free of charge to the corresponding author. Additional offprints can be ordered at prices shown on the offprint order form that accompanies the galley proofs.
No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of the rapid advances made in the medical sciences, independent verification of diagnoses and drug dosages should be made.
6. Author enquiries
All questions arising after acceptance of a manuscript by the Editor, especially those relating to proofs, publication and reprints, should be directed to the Publisher: Elsevier Science Ireland Ltd, Brookvale Plaza, East Park, Shannon, Co., Clare, Ireland, Tel: +353-61-709600, Fax: +353-61-709100, E-mail: authorsupport@elsevier.com.
Please visit the Elsevier Science Author Gateway at http://authors.elsevier.com to track accepted articles and set up e-mail alerts to inform you of when the article status has changed. Information on artwork guidelines, copyright information, and frequently asked questions is also available.
Editorial Board
-
- Editor-in-Chief:
- C.G. Pitt, 1374 Hanover Lane, Ventura, CA 93001, USA. E-Mail: cpitt@prodigy.net
- Editor for Europe:
- W.E. Hennink, Department of Pharmaceutics, University of Utrecht, Sorbonnelaan 16, 3508 TB Utrecht, The Netherlands. E-mail: jcr@pharm.uu.nl
- Editors for Japan and the Far East:
- T. Nagai (Editor), E-mail: nagaijcr@hoshi.ac.jp
K. Takayama (Associate Editor), Department of Pharmaceutics, Hoshi University, Ebara, Shinagawa-ku, Tokyo 142-8501, Japan. E-mail: takayama@hoshi.ac.jp
- Review Editor:
- V.P. Torchilin, Dept. of Pharmaceutical Sciences, Northeastern University, Boston, MA, USA. E-mail: vtorchil@lynx.neu.edu
- Book Review Editor:
- R.A. Siegel, Department of Pharmaceutics WDH 9-177, University of Minnesota, 308 Harvard St. SE, Minneapolis, MN 55455, USA. E-mail: siege017@tc.umn.edu
- Founding Editors:
- J. Feijen, University of Twente
J. Heller, A.P. Pharma
- Editorial Board:
- M.J. Alonso, Santiago de Compostela, Spain
Y.H. Bae, Salt Lake City, UT, USA
J.P. Behr, Illkirch, France
P. Colombo, Parma, Italy
P. Couvreur, Chatenay Malabry, France
D.J.A. Crommelin, Utrecht, The Netherlands
S.C. De Smedt, Ghent, Belgium
R. Duncan, Cardiff, UK
D.R. Friend, Princeton, NJ, USA
B. Gander, Zürich, Switzerland
G. Golomb, Jerusalem, Israel
D.W. Grainger, Fort Collins, CO, USA
R. Gurny, Geneva, Switzerland
H. Harashima, Sapporo, Japan
M. Hashida, Kyoto, Japan
J.A. Hubbell, Zurich, Switzerland
S.Y. Jeong, Seoul, Korea
H.E. Junginger, Leiden, The Netherlands
A. Kabanov, Omaha, NE, USA
K. Kataoka, Tokyo, Japan
Y. Kawashima, Gifu, Japan
T. Kissel, Marburg, Germany
J. Kopecek, Salt Lake City, UT, USA
J. Kost, Beer-Sheeva, Israel
G.S. Kwon, Madison, WI, USA
S.J. Lee, Seoul, Korea
C.M. Lehr, Saarbrücken, Germany
K.W. Leong, Baltimore, MD, USA
H. Maeda, Kumamoto, Japan
E. Mathiowitz, Providence, RI, USA
A.G. Mikos, Houston, TX, USA
T. Okano, Tokyo, Japan
K. Park, West Lafayette, IN, USA
N.A. Peppas, Austin, TX, USA
R.O. Potts, San Francisco, CA, USA
M. Prausnitz, Atlanta, GA, USA
A.P. Rolland, San Diego, CA, USA
W.M. Saltzman, New Haven, CT, USA
Y. Sugiyama, Tokyo, Japan
J. Sunamoto, Shiga, Japan
K. Ulbrich, Prague, Czech Republic
A. Urtti, Kuopio, Finland
|
刊名字顺( Alphabetical List of Journals):
返回页首 